172 related articles for article (PubMed ID: 18618022)
1. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice.
Jiang M; Bujo H; Ohwaki K; Unoki H; Yamazaki H; Kanaki T; Shibasaki M; Azuma K; Harigaya K; Schneider WJ; Saito Y
J Clin Invest; 2008 Aug; 118(8):2733-46. PubMed ID: 18618022
[TBL] [Abstract][Full Text] [Related]
2. Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes.
Jin W; Jiang M; Han X; Han X; Murano T; Hiruta N; Ebinuma H; Piao L; Schneider WJ; Bujo H
Clin Chim Acta; 2016 Jun; 457():137-41. PubMed ID: 27095609
[TBL] [Abstract][Full Text] [Related]
3. LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration.
Zhu Y; Bujo H; Yamazaki H; Ohwaki K; Jiang M; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
Circ Res; 2004 Apr; 94(6):752-8. PubMed ID: 14764453
[TBL] [Abstract][Full Text] [Related]
4. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro.
Zhu Y; Bujo H; Yamazaki H; Hirayama S; Kanaki T; Takahashi K; Shibasaki M; Schneider WJ; Saito Y
Circulation; 2002 Apr; 105(15):1830-6. PubMed ID: 11956127
[TBL] [Abstract][Full Text] [Related]
6. Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosis.
Harada M; Jiang M; Terai K; Ebinuma H; Hiruta N; Schneider WJ; Sugo N; Nagao T; Bujo H
Clin Chim Acta; 2019 Mar; 490():69-76. PubMed ID: 30550937
[TBL] [Abstract][Full Text] [Related]
7. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells.
Jiang M; Bujo H; Zhu Y; Yamazaki H; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
Biochem Biophys Res Commun; 2006 Oct; 348(4):1367-77. PubMed ID: 16919601
[TBL] [Abstract][Full Text] [Related]
8. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.
Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT
Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897
[TBL] [Abstract][Full Text] [Related]
9. The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells.
Nishii K; Nakaseko C; Jiang M; Shimizu N; Takeuchi M; Schneider WJ; Bujo H
J Biol Chem; 2013 Apr; 288(17):11877-86. PubMed ID: 23486467
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
Ogita M; Miyauchi K; Kasai T; Tsuboi S; Wada H; Naito R; Konishi H; Dohi T; Tamura H; Okazaki S; Yanagisawa N; Shimada K; Suwa S; Jiang M; Bujo H; Daida H
Atherosclerosis; 2016 Jan; 244():216-21. PubMed ID: 26687467
[TBL] [Abstract][Full Text] [Related]
11. A secreted soluble form of LR11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipid-laden macrophages.
Ohwaki K; Bujo H; Jiang M; Yamazaki H; Schneider WJ; Saito Y
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1050-6. PubMed ID: 17332490
[TBL] [Abstract][Full Text] [Related]
12. Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury.
Ogita M; Miyauchi K; Jiang M; Kasai T; Tsuboi S; Naito R; Konishi H; Dohi T; Yokoyama T; Okazaki S; Shimada K; Bujo H; Daida H
Atherosclerosis; 2014 Nov; 237(1):374-8. PubMed ID: 25443876
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells.
Kohno M; Yokokawa K; Kano H; Yasunari K; Minami M; Hanehira T; Yoshikawa J
Hypertension; 1997 Jun; 29(6):1309-13. PubMed ID: 9180634
[TBL] [Abstract][Full Text] [Related]
14. [Biomarkers for Atherosclerotic Diseases: Significance of Intimal Smooth Muscle Cell-Derived Circulating Marker].
Bujo H
Rinsho Byori; 2016 Jun; 64(6):651-656. PubMed ID: 30695319
[TBL] [Abstract][Full Text] [Related]
15. Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis.
Matsuo M; Ebinuma H; Fukamachi I; Jiang M; Bujo H; Saito Y
Clin Chem; 2009 Oct; 55(10):1801-8. PubMed ID: 19661140
[TBL] [Abstract][Full Text] [Related]
16. Enhanced circulating soluble LR11 in patients with coronary organic stenosis.
Takahashi M; Bujo H; Jiang M; Noike H; Saito Y; Shirai K
Atherosclerosis; 2010 Jun; 210(2):581-4. PubMed ID: 20047743
[TBL] [Abstract][Full Text] [Related]
17. Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells.
Kohno M; Ohmori K; Nozaki S; Mizushige K; Yasunari K; Kano H; Minami M; Yoshikawa J
Hypertens Res; 2000 Nov; 23(6):677-81. PubMed ID: 11131281
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
19. Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions.
Kanaki T; Bujo H; Hirayama S; Ishii I; Morisaki N; Schneider WJ; Saito Y
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2687-95. PubMed ID: 10559012
[TBL] [Abstract][Full Text] [Related]
20. G-CSF induces the release of the soluble form of LR11, a regulator of myeloid cell mobilization in bone marrow.
Shimizu N; Nakaseko C; Jiang M; Nishii K; Yokote K; Iseki T; Higashi M; Tamaru J; Schneider WJ; Bujo H
Ann Hematol; 2014 Jul; 93(7):1111-22. PubMed ID: 24577511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]